Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Calcium signaling pathway | R-HSA-381753 | map04020 | (-)-MK-801 | 16219612 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | fluspirilene | 72287 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | fluspirilene | 72287 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | fluspirilene | 72287 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | fluspirilene | 72287 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | fluspirilene | 72287 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | fluspirilene | 72287 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | megestrol | 19090 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | megestrol | 19090 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | megestrol | 19090 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | megestrol | 19090 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | benzbromarone | 3690 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | benzbromarone | 3690 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | benzbromarone | 3690 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | benzbromarone | 3690 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | benzbromarone | 3690 | drug-path |
| Basal cell carcinoma | R-HSA-5626181 | map05217 | benzbromarone | 3690 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | prasterone | 5881 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | prasterone | 5881 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | prasterone | 5881 | drug-path |